KeyBanc cuts Teradyne stock rating amid trade uncertainty

Published 17/04/2025, 06:58
KeyBanc cuts Teradyne stock rating amid trade uncertainty

On Thursday, KeyBanc Capital Markets adjusted its stance on Teradyne (NASDAQ:TER), a leading provider of automated test equipment, by downgrading its stock rating from Overweight to Sector Weight. The stock, currently trading at $71.16, has experienced significant pressure, falling over 43% year-to-date. According to InvestingPro analysis, Teradyne currently appears undervalued based on its Fair Value assessment. The move by KeyBanc’s analyst Steve Barger was driven by concerns over increasing global trade uncertainties and Teradyne’s limited visibility within this challenging environment.

Barger noted that while Teradyne could potentially benefit from strong operating leverage during a broader market upcycle, the current pressures on high-volume end markets, particularly in the Automotive and Mobile sectors, warrant a more cautious approach. As a result, KeyBanc has chosen to revise its estimates for Teradyne, reflecting these market conditions. Despite market challenges, the company maintains strong fundamentals with a healthy gross profit margin of 58.5% and an impressive return on equity of 20%.

Despite the downgrade, KeyBanc remains optimistic about Teradyne’s long-term prospects. Barger believes that well-defined industry trends could lead to significant revenue and earnings per share (EPS) growth for the company. However, he also expects that Teradyne’s performance may experience more volatility compared to other companies within the semiconductor capital equipment sector. The company’s next earnings report is scheduled for April 28, with analysts forecasting EPS of $3.36 for fiscal year 2025. InvestingPro subscribers have access to 10+ additional exclusive insights about Teradyne’s financial health and market position.

The analyst’s commentary underscores the delicate balance that Teradyne must navigate. While the company stands to gain from industry growth over the long haul, the path to achieving these gains is anticipated to be uneven, especially in the face of the current global trade landscape. Notably, Teradyne maintains a strong financial position with more cash than debt on its balance sheet and a current ratio of 2.91, indicating solid liquidity.

Investors and market watchers will likely monitor Teradyne closely to see how the company adapts to these near-term challenges while positioning itself to capitalize on the eventual market recovery and the anticipated upswing in its core end markets. For a comprehensive analysis of Teradyne’s market position and future prospects, investors can access the detailed Pro Research Report available exclusively on InvestingPro, which provides in-depth insights into the company’s fundamentals and growth potential.

In other recent news, several analysts have adjusted their price targets and outlooks for Teradyne. Morgan Stanley (NYSE:MS) lowered its price target from $81 to $69, maintaining an Underweight rating due to a tempered outlook in key markets such as automotive and industrial sectors. This revision includes reduced revenue and earnings expectations for 2025 and 2026. Northland Securities also cut its price target from $140 to $105 but kept an Outperform rating, citing near-term tariff uncertainties while remaining optimistic about long-term growth driven by market expansion and strategic initiatives.

TD Cowen decreased its price target from $135 to $110, maintaining a Buy rating, following Teradyne’s revised guidance indicating challenges in the semiconductor testing segment. UBS reduced its price target from $155 to $130, also maintaining a Buy rating, and noted Teradyne’s operational expense reductions amid short-term softness in semiconductor testing. Lastly, Stifel lowered its price target from $125 to $110, holding a Hold rating, while acknowledging Teradyne’s strategic positioning in the AI sector and semiconductor test market. These developments reflect a cautious yet varied outlook among analysts regarding Teradyne’s financial performance and strategic direction.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.